Long-awaited exposure draft on SPV consolidation released in US

The US Financial Accounting Standards Board (FASB) has released a long-awaited exposure draft on the consolidation of special purpose entities, or special purpose vehicles (SPVs). New rules for accounting for SPVs, a class that includes all CDOs, was made politically urgent by energy trader Enron’s ethically questionable use of SPVs to enrich senior executives and hide company losses.

Under the proposed interpretation in the exposure draft, all SPVs with 10% equity or less would be candidates for consolidation on the balance sheets of a special class of SPV investor called the 'primary beneficiary'. According to the exposure draft, the primary beneficiary holds the majority stake or the largest share of that class of SPV securities with the greatest variability in returns. In CDOs, that class would be the equity tranche, or first-loss piece.

One CDO analyst familiar with the exposure draft, speaking on condition of anonymity, was upbeat about the new document. When the consolidation issue was first being aired by the FASB in March, officials in the CDO business were concerned that stringent regulations would cut CDO volume by requiring consolidation of the structures on the balance sheets of publicly owned investors. The fear was that investors in these companies would penalise the companies for having their CDO investments on-balance sheet.

According to the CDO analyst, on a preliminary reading, the interpretation in the new exposure draft seems to allow managed CDOs to remain exempt from consolidation, regardless of the equity class comprising their capital structure. The analyst said it was unclear how the interpretation applied to synthetic CDOs, as there was no explicit reference in the exposure draft to derivatives.

The comment period for the new exposure draft concludes on August 30, 2002.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here